Cannabis

Does Cannabis Dilate Pupils? Myths vs. Medical Facts

Lead Psychologist

Sep 5, 2025

Does cannabis dilate pupils, or is that just another drug myth? While many believe marijuana causes large, wide-open pupils, recent optical health research says otherwise. Using advanced infrared videography, scientists found cannabis actually reduces normal pupil constriction after light exposure rather than causing true dilation.¹ This means the classic “stoned look” may have more to do with red eyes and eyelid droop than enlarged pupils. In this article, we will delve into the science, dispel common misconceptions, and clarify the true effects of cannabis on your eyes.


Key Takeaways

  • Cannabis does not consistently cause pupil dilation.

  • The main effect of cannabis is reduced pupil constriction and a slower recovery time after exposure to light.

  • Pupil changes from cannabis differ from those caused by stimulants or hallucinogens.

  • Red eyes and eyelid changes are far more reliable cannabis indicators than pupil size.


What the Latest Science Says About Cannabis and Pupils

When it comes to cannabis and pupil size, modern clinical evidence tells a very different story than the one found in pop culture or outdated drug detection manuals.


Reduced Pupil Constriction, Not True Dilation

A controlled study involving 84 participants tested pupil responses to light after smoking cannabis. The results showed that cannabis use was associated with less initial constriction and reduced sustained constriction compared to non-users.²

This means that while pupils might appear slightly larger than normal in a bright environment, the effect is due to a blunted pupillary light reflex—not actual drug-induced mydriasis. In practical terms, cannabis doesn’t “blow out” your pupils like stimulants or hallucinogens; it simply slows the reflex that makes them constrict in response to light.


Why the Cannabis-Dilated Pupils Myth Persists

Even though research shows cannabis does not consistently dilate pupils, the myth remains widespread. One reason is that cannabis can cause pupil size variability—small, moment-to-moment changes in diameter—that some observers mistake for dilation.


The Role of THC Levels

A 2024 study found that pupil diameter changes strongly correlated with THC concentration in the blood (r = 0.81–0.86).³ However, these changes reflected reduced responsiveness rather than a uniform increase in size. The pupils weren’t “locked” in a dilated state—they simply adjusted less dynamically to light.

When viewed in dim lighting (common in social or recreational cannabis settings), this sluggish adjustment can make pupils look larger, fuelled by the misconception that cannabis causes true mydriasis.


Cannabis Effects in Forensic and Driving Contexts

Pupil size has long been part of roadside impairment checks, but cannabis challenges this approach.


Pupil Size as a Forensic Marker

A driving simulator study measured THC blood levels alongside eye-tracking data. The researchers found that mean pupil diameter correlated with THC concentration (r = 0.81–0.86), but primarily due to impaired reactivity, not sustained dilation.

This means that while pupillometry can detect cannabis-related visual function changes, it’s a poor standalone indicator of intoxication. Instead, law enforcement and forensic toxicologists are shifting toward functional measures—like saccade speed and tracking accuracy—rather than relying on pupil size alone.


Debunking Other Visual Myths About Cannabis

Cannabis eye effects are often misunderstood, with myths extending beyond pupil size. One common belief is that cannabis causes eyelid tremors, supposedly making it easier to detect impairment in roadside exams.


The Eyelid Tremor Myth

A controlled study of 103 participants found no significant association between recent cannabis use and eyelid tremor 70 minutes after smoking. This means tremors are not a reliable detection sign and should not be used in isolation to assess impairment.

Instead, cannabis’s visual signs are more consistently linked to conjunctival redness and delayed pupil light response, both of which are subtle and require trained observation.


Table 1: Cannabis vs. Other Drug Eye Effects

Substance Category

Typical Pupil Effect

Other Common Eye Signs

Reliability for Detection

Cannabis

Reduced constriction response

Redness, dryness, possible ptosis

Low (pupil size inconsistent)

Stimulants (cocaine, amphetamine)

True dilation (mydriasis)

Brightness sensitivity, lid retraction

High

Hallucinogens (LSD, PCP)

True dilation (mydriasis)

Nystagmus, abnormal tracking

High

Opioids

Constriction (miosis)

Droopy eyelids, sluggish tracking

High

Alcohol

No consistent change

Redness, delayed reflexes

Low

Key Insight: Cannabis does not fit into the “mydriatic drug” category. Its main effect is on pupil reflex speed, not sustained diameter, which is why it’s unreliable for quick visual detection compared to stimulants or hallucinogens.


How Cannabinoids Affect the Eye’s Neurobiology

To understand why cannabis doesn’t cause consistent dilation, it helps to look at what cannabinoids do inside the eye.


Cannabinoids in the Retina

The retina contains cannabinoid receptors that influence neurotransmitter release. A foundational review found that cannabinoids suppress dopamine release and reduce transmitter release from retinal cells.

Since dopamine plays a role in pupil control, reducing its activity can blunt the pupillary light reflex without directly triggering mydriasis. This explains why cannabis users may have slower pupil constriction after light exposure but no fixed enlargement.

Additionally, cannabinoids interact with the parasympathetic nervous system—responsible for constricting pupils—which further supports the finding that cannabis leans toward reduced constriction rather than dilation.


Eyelid and Surrounding Eye Effects

Cannabis may not dramatically change pupil size, but it can affect the tissues around the eye in ways that alter appearance.


Ptosis and Eyelid Relaxation

A comprehensive review of 20 studies found cannabis use is associated with ptosis (drooping eyelids), reduced eyelid tremor, and attenuation of blepharospasm (involuntary eyelid twitching).

While these effects don’t involve the pupil directly, they can contribute to the stereotypical “sleepy-eyed” look often associated with cannabis use. This appearance, combined with conjunctival redness, may be mistakenly attributed to dilated pupils—especially in casual observation without proper lighting.

Key takeaway: Cannabis alters eye presentation more through eyelid tone and redness than through actual pupil enlargement.


What Classic Ophthalmology Studies Reveal

Decades before modern infrared eye-tracking, ophthalmologists were already testing cannabinoids’ effects directly on the eye.


Topical THC and Pupil Size

A classic clinical study applied delta-9-tetrahydrocannabinol (THC) topically to human eyes and found it caused miosis—pupil constriction—rather than dilation. This effect was mild but measurable, directly contradicting the popular belief that cannabis enlarges pupils.

The study supports the idea that cannabinoids have parasympathomimetic effects on the pupil, activating pathways that encourage constriction instead of expansion.

This early finding aligns with modern research showing cannabis changes pupil reactivity rather than baseline size, and it reinforces that cannabis should not be grouped with drugs that cause true mydriasis.


Cannabis, Eye Pressure, and Vision Changes

One of the earliest recognised medical uses of cannabis was glaucoma treatment, thanks to its ability to lower intraocular pressure (IOP).


Eye Pressure Reduction Without Dilation

In a clinical study of glaucoma patients, cannabis significantly reduced IOP but produced no consistent changes in pupil size. The primary effects were vascular—improving fluid drainage in the eye—rather than altering the muscles that control pupil diameter.

The study is important because it shows that even when cannabis exerts strong ocular effects, true mydriasis does not occur. Patients experienced symptom relief for glaucoma without any of the fixed, wide pupils seen in stimulant or anticholinergic drug use.


How Cannabis Differs From True Mydriatic Drugs

True mydriasis—sustained pupil dilation—is a hallmark of certain drug classes, but cannabis isn’t one of them.


Pharmacological Comparison

A review comparing ocular effects across substances placed cannabis outside the mydriatic drug category.¹⁰ Mydriatic agents include:

  • Anticholinergics, such as atropine and scopolamine, inhibit parasympathetic input, leading to the retention of large pupils.


  • Stimulants such as cocaine and amphetamines activate sympathetic pathways, causing pupils to widen.


Cannabis, in contrast, influences the endocannabinoid system, producing mild parasympathetic effects that often favour constriction or slowed constriction, not enlargement.

This classification explains why medical and forensic experts caution against assuming dilated pupils are a reliable cannabis indicator.


Toxicology Reviews and Pupil Misconceptions

Toxicologists have long recognised that cannabis intoxication presents itself differently than other drugs when it comes to ocular signs.


Absence of Consistent Mydriasis

A comprehensive toxicology review concluded that consistent pupil dilation is not part of cannabis’s intoxication profile.¹¹ Unlike stimulants or hallucinogens, cannabis typically causes conjunctival redness, mild eyelid drooping, and changes in reaction time—but not fixed, wide pupils.

This distinction is critical in medical and law enforcement settings, where relying on pupil size alone could lead to false positives for cannabis impairment or confusion with other substances that truly cause mydriasis.

Bottom line: Cannabis eye effects are subtle and functional, not grossly anatomical like those caused by stimulant or anticholinergic drugs.


Why Whole-Plant Cannabis Rarely Dilates Pupils

If THC can, in theory, influence autonomic control of the pupils, why doesn’t cannabis use consistently cause dilation? The answer may lie in the plant’s complex chemical profile.


Balancing Effects of THC and CBD

A mechanistic study found that CBD can inhibit endocannabinoid signalling in certain neurones, potentially counteracting any mild mydriatic effects of THC.¹² When consumed together—as in most whole-plant cannabis—these compounds may balance each other out, resulting in minimal or no net change in pupil size.

This chemical interplay helps explain why pure THC isolates could theoretically affect pupils differently than natural cannabis flower or full-spectrum extracts and why real-world cannabis use produces inconsistent ocular changes.


Cannabinoids and Glaucoma Research

Cannabinoids have been extensively studied for their potential in glaucoma management, but the focus has always been on intraocular pressure (IOP)—not pupil size.


Primary Effects Are Vascular

A clinical review found that cannabinoids primarily act by reducing IOP and improving ocular blood flow, with no consistent changes in pupil diameter.¹³ These effects are beneficial for glaucoma patients but irrelevant to the idea of mydriasis.

This reinforces the medical consensus: even when cannabis exerts measurable changes in ocular physiology, pupil dilation is not one of them. Instead, its visual impact is functional—affecting reflex speed and vascular tone—rather than structural enlargement of the pupils.


Modern Eye-Tracking for Cannabis Detection

Advances in technology have shifted cannabis detection away from outdated pupil-size checks toward functional eye performance testing.


Focus on Movement, Not Size

A 2024 study using head-mounted eye-tracking displays found cannabis use impaired saccade performance (rapid eye movements) and visual tracking accuracy, but pupil size changes were inconsistent and minor.¹⁴

These findings confirm that while cannabis can measurably affect how the eyes work, it does not reliably alter how they look in terms of pupil diameter. Forensic and clinical assessments are increasingly focusing on metrics like reaction speed and gaze stability rather than the unreliable indicator of "dilated pupils".


Final Word from Comprehensive Drug–Ocular Effect Reviews

When cannabis is evaluated alongside other psychoactive substances, its ocular profile stands out for what it doesn’t do.


Not in the Mydriatic Club

A significant review of drug-induced eye changes classified cannabis among substances that cause conjunctival hyperaemia (red eyes) and reduced tear production, but not consistent pupil dilation.¹⁵

True mydriatic substances—like anticholinergics, stimulants, and hallucinogens—act on the eye’s muscles or neural pathways in a way cannabis simply doesn’t. This category aligns with decades of clinical and forensic evidence: while cannabis affects the eyes in several noticeable ways, dilated pupils are not one of its reliable signs.


Harm Reduction and Public Awareness

Understanding what cannabis does—and doesn’t—do to your pupils isn’t just about correcting a myth. It has real-world implications for health, safety, and law enforcement.


For Users

  • Don’t assume eye appearance can reliably “hide” or “prove” cannabis use.


  • Be aware that other eye effects—like redness, dryness, and slower reflexes—are more consistent.


  • If you experience unusual or persistent changes in vision, seek an ophthalmologic exam, as cannabis can influence ocular blood flow and reflexes.


For Professionals

  • Avoid using pupil size alone to infer cannabis intoxication; it’s not supported by evidence.


  • Utilise functional measures (such as eye-tracking and coordination tests) for more accurate detection of impairment.


  • Educate patients and clients on the difference between cannabis effects and those of true mydriatic drugs.


Bottom line: Public health messaging should focus on evidence-based signs of cannabis use—red eyes, delayed reflexes—not outdated pupil myths.


Table 2: Cannabis Eye Effects – Myths vs. Medical Facts

Common Belief About Cannabis Eyes

Scientific Finding

Key References

Cannabis makes pupils very large

No consistent dilation; slows light reflex

1, 2, 3

Pupil size is a reliable detector

Unreliable; functional eye tests are better

14

All users will have “stoned eyes”

Redness more common than pupil changes

7, 8

Cannabis acts like stimulants

Pharmacology is different; it is not a true mydriatic

10, 15

Pupil changes last for hours

Effects on light reflex are short-lived

3, 4


Frequently Asked Questions (FAQs)


1. Does cannabis dilate pupils?

No. Cannabis does not consistently cause pupil dilation. It mainly reduces the speed and extent of pupil constriction in response to light.


2. Why do people think cannabis causes dilated pupils?

Myths come from low-light settings, mixed drug use, and outdated law enforcement training. Research shows cannabis affects reflexes, not baseline size.


3. What are reliable eye signs of cannabis use?

Conjunctival redness, eyelid drooping (ptosis), and delayed pupillary light reflex are far more consistent than dilation.


4. Can cannabis pupil effects be used to detect impairment?

Pupil size is unreliable. Modern impairment detection focuses on functional measures like saccadic eye movements and tracking accuracy.


5. Do THC and CBD affect pupils differently?

Yes. THC can mildly influence pupil control, but CBD may counteract it, making whole-plant cannabis unlikely to cause consistent dilation.


6. Which drugs cause pupil dilation?

True mydriasis occurs with stimulants (cocaine, amphetamines), hallucinogens (LSD, PCP), and anticholinergics (atropine)—not cannabis.


Conclusion: Does Cannabis Dilate Pupils?

The evidence is clear: cannabis does not consistently dilate pupils. Instead, it tends to slow or reduce the normal constriction of the pupil in response to light. While popular culture and outdated training manuals have long linked cannabis with “big pupils”, this effect is neither reliable nor supported by modern science.

The real ocular signs of cannabis use—such as conjunctival redness, reduced tear production, and delayed light reflex—are far more accurate indicators. True mydriasis is caused by stimulant drugs, hallucinogens, and certain medications—not cannabis.

Understanding the difference matters. For law enforcement, medical professionals, and everyday people, accurate knowledge reduces false assumptions, supports fair assessments, and promotes evidence-based cannabis education.

Therefore, the next time someone asks, “Does cannabis dilate pupils?”—you can answer confidently: No, it’s a myth—and here’s what science really says.


References

  1. Steinhart B, Brooks-Russell A, Kosnett MJ, Subramanian PS, Wrobel J. A Video Segmentation Pipeline for Assessing changes in Pupil Response to Light After Cannabis Consumption. bioRxiv [Preprint]. 2023 Mar 21:2023.03.17.533144. doi: 10.1101/2023.03.17.533144. PMID: 36993434; PMCID: PMC10055178.

  2. Godbole S, Leroux A, Brooks-Russell A, Subramanian PS, Kosnett MJ, Wrobel J. A Study of Pupil Response to Light as a Digital Biomarker of Recent Cannabis Use. Digit Biomark. 2024 Apr 26;8(1):83-92. doi: 10.1159/000538561. PMID: 38682092; PMCID: PMC11052563.

  3. Haider MN, Regan D, Hoque M, Ali F, Ilowitz A. Effects of recent cannabis consumption on eye-tracking and pupillometry. Front Neurosci. 2024 Apr 9;18:1358491. doi: 10.3389/fnins.2024.1358491. PMID: 38655106; PMCID: PMC11036868.

  4. Shahidi Zandi A, Comeau FJE, Mann RE, Di Ciano P, Arslan EP, Murphy T, Le Foll B, Wickens CM. Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving. Cannabis Cannabinoid Res. 2021 Dec;6(6):537-547. doi: 10.1089/can.2020.0141. Epub 2021 Aug 24. PMID: 34432541; PMCID: PMC8713278.

  5. Spindle TR, Cone EJ, Goffi E, Weerts EM, Mitchell JM, Winecker RE, Bigelow GE, Flegel RR, Vandrey R. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend. 2020 Jun 1;211:107937. doi: 10.1016/j.drugalcdep.2020.107937. Epub 2020 Apr 1. PMID: 32247649; PMCID: PMC7414803.

  6. Yazulla S. Endocannabinoids in the retina: from marijuana to neuroprotection. Prog Retin Eye Res. 2008 Sep;27(5):501-26. doi: 10.1016/j.preteyeres.2008.07.002. Epub 2008 Aug 3. PMID: 18725316; PMCID: PMC2584875.

  7. Schwitzer T, Schwan R, Albuisson E, et al. Association Between Regular Cannabis Use and Ganglion Cell Dysfunction . JAMA Ophthalmol. 2017;135(1):54–60. doi:10.1001/jamaophthalmol.2016.4761

  8. Green K, Roth M. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man. Arch Ophthalmol. 1982 Feb;100(2):265-7. doi: 10.1001/archopht.1982.01030030267006. PMID: 6279061.

  9. Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980 Mar;87(3):222-8. doi: 10.1016/s0161-6420(80)35258-5. PMID: 7053160.

  10. Sharma P, Murthy P, Bharath MM. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry. 2012 Fall;7(4):149-56. PMID: 23408483; PMCID: PMC3570572.

  11. Grotenhermen F. The toxicology of cannabis and cannabis prohibition. Chem Biodivers. 2007 Aug;4(8):1744-69. doi: 10.1002/cbdv.200790151. PMID: 17712818.

  12. Straiker A, Dvorakova M, Zimmowitch A, Mackie K. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Mol Pharmacol. 2018 Jul;94(1):743-748. doi: 10.1124/mol.118.111864. Epub 2018 Apr 18. PMID: 29669714; PMCID: PMC5988021.

  13. Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol. 2004 May;88(5):708-13. doi: 10.1136/bjo.2003.032250. PMID: 15090428; PMCID: PMC1772142.

  14. Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015 Sep 1;154:25-37. doi: 10.1016/j.drugalcdep.2015.06.015. Epub 2015 Jun 23. PMID: 26144593; PMCID: PMC4536116.

  15. Kacinko SL, Mohr ALA, Logan BK, Barbieri EJ. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework. J Anal Toxicol. 2022 Oct 14;46(8):911-917. doi: 10.1093/jat/bkac049. PMID: 35770859.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Copyright © 2025 Sunflower Limited. All rights reserved.

Copyright © 2025 Sunflower Limited. All rights reserved.

Copyright © 2025 Sunflower Limited. All rights reserved.